Status:
COMPLETED
ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease
Lead Sponsor:
OPKO Health, Inc.
Conditions:
Alzheimer's Disease
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the long-term safety and tolerability of ELND005 beyond the 18 months of treatment in original randomized and blinded clinical trail ELND005-AD201.
Eligibility Criteria
Inclusion
- This study is open only to subjects who have completed the week 78 visit in Study ELND005-AD201 while taking their assigned dose of study drug medication.
Exclusion
- Subject has no new medical contraindications to continued participation in the study.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT00934050
Start Date
June 1 2009
End Date
June 1 2011
Last Update
October 21 2019
Active Locations (38)
Enter a location and click search to find clinical trials sorted by distance.
1
Banner Alzheimer's Institute
Phoenix, Arizona, United States, 85006
2
Sun Health Research Institute
Sun City, Arizona, United States, 85351
3
University of Arizona, Health Sciences Center, Dept. of Neurology
Tucson, Arizona, United States, 85724
4
Margolin Brain Institute
Fresno, California, United States, 93720